Brittany Avin McKelvey, Senior Director of Regulatory Policy at LUNGevity Foundation, shared on LinkedIn:
”Excellent discussions at American Association for Cancer Research D3 meeting!
An honor to discuss emerging regulatory trends with Richard Pazdur, Jon Retzlaff, Rasika Kalamegham, Patricia LoRusso, ensuring that the US will continue to be a leader in developing transformative drugs.
Our LUNGevity Foundation poster on interpretation of duration of response endpoints caused quite the discussion, and I look forward to continuing the dialogue to ensure trial endpoints are meaningful and rigorous.”
Other articles featuring Brittany Avin McKelvey on OncoDaily.